phosphorylcholine has been researched along with Metabolic Syndrome in 3 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Central obesity was found in 57% of the women (waist circumference >80 cm) and in 89% of the men (waist circumference >94 cm)." | 5.35 | Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study. ( Cederholm, T; Elkan, AC; Frostegård, J; Hafström, I; Håkansson, N, 2009) |
| "Phosphorylcholine (PC) is an epitope on oxidized low-density lipoprotein, dead cells and some microorganisms." | 1.62 | Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjects. ( Bachus, E; Bhattacharya, P; Engström, G; Frostegård, J; Holm, H; Jujić, A; Korduner, J; Magnusson, M; Nilsson, PM, 2021) |
| "Central obesity was found in 57% of the women (waist circumference >80 cm) and in 89% of the men (waist circumference >94 cm)." | 1.35 | Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study. ( Cederholm, T; Elkan, AC; Frostegård, J; Hafström, I; Håkansson, N, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jujić, A | 1 |
| Korduner, J | 1 |
| Holm, H | 1 |
| Engström, G | 1 |
| Bachus, E | 1 |
| Bhattacharya, P | 1 |
| Nilsson, PM | 1 |
| Frostegård, J | 2 |
| Magnusson, M | 1 |
| El-Najjar, N | 1 |
| Orsó, E | 1 |
| Wallner, S | 1 |
| Liebisch, G | 1 |
| Schmitz, G | 1 |
| Elkan, AC | 1 |
| Håkansson, N | 1 |
| Cederholm, T | 1 |
| Hafström, I | 1 |
3 other studies available for phosphorylcholine and Metabolic Syndrome
| Article | Year |
|---|---|
Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjects.
Topics: Aged; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Hospitalization; Humans; Immunoglo | 2021 |
Increased Levels of Sphingosylphosphorylcholine (SPC) in Plasma of Metabolic Syndrome Patients.
Topics: Biomarkers; Female; Humans; Inflammation; Lipids; Lysophospholipids; Male; Metabolic Syndrome; Middl | 2015 |
Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study.
Topics: Aged; Antibodies; Arthritis, Rheumatoid; Body Mass Index; Cachexia; Cross-Sectional Studies; Dietary | 2009 |